Injectable codeine is readily available for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this may lead to nonimmune mast-mobile degranulation and ensuing anaphylactoid response. Codeine suppositories are also marketed in certain nations. In Eire, new restrictions arrived into impact on 1 August 2010[ninety] about codeine, because of https://codeingil.com/